"Nucleus Network, formerly Prism Clinical Research is clinical trial facility in St. Paul, MN specializing in trials for healthy volunteers and those with kidney and liver disease. All screening appointments, inpatient stays and outpatient visits take place at this facility."

During the past decade, Prism Research LLC dba Nucleus Network conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prism Research LLC dba Nucleus Network" #1 sponsor was "Pfizer" with 12 trials, followed by "Shionogi" with 2 trials sponsored, "AN2 Therapeutics, Inc" with 1 trials sponsored, "Astellas Pharma Global Development, Inc." with 1 trials sponsored and "Canopy Growth Corporation" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prism Research LLC dba Nucleus Network" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Prism Research LLC dba Nucleus Network" are "Renal Impairment" (6 trials), "Healthy" (3 trials), "Healthy Volunteers" (3 trials), "Hepatic Impairment" (3 trials) and "Renal Insufficiency" (2 trials). Many other conditions were trialed in "Prism Research LLC dba Nucleus Network" in a lesser frequency.

Most popular intervention types in "Prism Research LLC dba Nucleus Network" are "Drug" (17 trials), "Other" (3 trials), "Biological" (2 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "S-217622" (2 trials), "13vPnC" (1 trials), "ASP0367" (1 trials), "Aztreonam-Avibactam" (1 trials) and "Candidate Control" (1 trials). Other intervention names were less common.

The vast majority of trials in "Prism Research LLC dba Nucleus Network" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Prism Research LLC dba Nucleus Network". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Prism Research LLC dba Nucleus Network, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Prism Research LLC dba Nucleus Network, 20 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".